Business Description
Marvel Biosciences Corp
NAICS : 541710
SIC : 3741
ISIN : CA57384M1077
Description
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | -5.79 | |||||
Debt-to-Equity | -0.51 | |||||
Debt-to-EBITDA | -1.3 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.3 | |||||
3-Year EPS without NRI Growth Rate | 24.1 | |||||
3-Year FCF Growth Rate | 29 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.57 | |||||
9-Day RSI | 35.72 | |||||
14-Day RSI | 41.38 | |||||
3-1 Month Momentum % | -4.91 | |||||
6-1 Month Momentum % | -2.65 | |||||
12-1 Month Momentum % | 0.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.18 | |||||
Quick Ratio | 0.18 | |||||
Cash Ratio | 0.17 | |||||
Days Payable | 1407.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | -3.57 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -302 | |||||
ROIC % | -43.9 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -10.14 | |||||
EV-to-EBITDA | -10.14 | |||||
EV-to-FCF | -14.05 | |||||
Earnings Yield (Greenblatt) % | -9.86 | |||||
FCF Yield % | -7.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MBCOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marvel Biosciences Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.029 | ||
| Beta | 1.6508 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 112.22 | ||
| 14-Day RSI | 41.38 | ||
| 14-Day ATR ($) | 0.013163 | ||
| 20-Day SMA ($) | 0.127386 | ||
| 12-1 Month Momentum % | 0.28 | ||
| 52-Week Range ($) | 0.0892 - 0.241 | ||
| Shares Outstanding (Mil) | 63.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Marvel Biosciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Marvel Biosciences Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Marvel Biosciences Corp Frequently Asked Questions
What is Marvel Biosciences Corp(MBCOF)'s stock price today?
The current price of MBCOF is $0.12. The 52 week high of MBCOF is $0.24 and 52 week low is $0.09.
When is next earnings date of Marvel Biosciences Corp(MBCOF)?
The next earnings date of Marvel Biosciences Corp(MBCOF) is .
Does Marvel Biosciences Corp(MBCOF) pay dividends? If so, how much?
Marvel Biosciences Corp(MBCOF) does not pay dividend.
Guru Commentaries on OTCPK:MBCOF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Marvel Biosciences Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers